Anaptys Biosciences Raises $33.9M

San Diego-based Anaptys Biosciences, a biotech firm developing therapeutic antibodies, said last week that it has raised $33.9M in a Series B financing round. The funding came from Novo A/S, and also included Frazier Healthcare Ventures, Alloy Ventures, and Avalon Ventures. The firm also said that Numenor Ventures, WS Investment Company, and Dr. Nick Lydon also participated in the funding. Anaptys said that the funding round will go towards advancement of the firm's novel technology for therapeutic antibody discovery and optimization. More information »